DolceRx Baltika is a biopharmaceutical company developing innovative solutions for the root cause of type 1 and type 2 Diabetes Mellitus by restoring β-cell proliferation in patient‘s pancreas. β-cell proliferation allows to restart the natural production of insulin by patient‘s pancreas and avoid the need for external intake through injections or other means.